ETF Managers Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,628
Closed -$217K 694
2020
Q4
$217K Sell
12,628
-1,906
-13% -$26.7K ﹤0.01% 571
2020
Q3
$172K Buy
14,534
+6,719
+86% +$89.2K 0.01% 584
2020
Q2
$100K Buy
+7,815
New +$93.9K ﹤0.01% 585

ETF Managers Group's OXFD Position: Q1 2021 in Review

ETF Managers Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 12,628 shares — an estimated $217K sold.

ETF Managers Group first reported a position in OXFD in Q2 2020 and held it in 3 quarters. The position peaked at $217K in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • ETF Managers Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • ETF Managers Group sold 12,628 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $217K.
  • ETF Managers Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 3 quarters.
  • ETF Managers Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $217K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on ETF Managers Group's 13F filing for Q1 2021, filed 17 May 2021.